Who Paid My Doc
Optisure Lead Post Approval Study
ClinicalTrials.gov NCT02235545
Research payments
$363,826
Through program year 2019, $363,826 in research payments was reported against Optisure Lead Post Approval Study, across 220 payments, paid by Abbott Laboratories.
- Paid by
- Abbott Laboratories
- ClinicalTrials.gov
- NCT02235545
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2019 | Research | $363,826 | 220 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- David Fitzgerald High Point, NC Named on 7 payments
- Ashish Sadhu Phoenix, AZ Named on 6 payments
- Daniel Schneider Mechanicsville, VA Named on 6 payments
- James Stone Tupelo, MS Named on 5 payments
- Ashok Talreja Fredericksburg, VA Named on 5 payments
- Daejoon Anh Henderson, NV Named on 5 payments
- Hirak Sen Albuquerque, NM Named on 5 payments
- Farhad Farokhi Rockford, IL Named on 5 payments
- Cesar Cruz Aguilar Atlanta, GA Named on 4 payments
- Michael Delaughter Bedford, TX Named on 4 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.